What are the severe side effects of Wegovy (semaglutide)?

Severe Side Effects of Wegovy (Semaglutide)

Wegovy carries serious risks including pancreatitis, gallbladder disease requiring surgery, acute kidney injury from dehydration, thyroid C-cell tumors (black box warning), diabetic retinopathy complications, and suicidal ideation—all of which require immediate medical attention if symptoms develop. 1

Life-Threatening and Severe Adverse Events

Thyroid C-Cell Tumors (Black Box Warning)

• Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) 1
• Rodent studies showed dose-dependent thyroid C-cell tumors; human relevance unknown 2, 3
• Monitor for neck mass, dysphagia, dyspnea, or persistent hoarseness 1

Acute Pancreatitis

• Reported in clinical trials; causality not definitively established but association exists 3
• Stop Wegovy immediately if severe abdominal pain occurs (may radiate to back), with or without vomiting 1
• Do not restart if pancreatitis confirmed 4, 1
• Use caution in patients with history of pancreatitis 5

Gallbladder Disease

• Increased risk of cholelithiasis and cholecystitis—some requiring surgery 3, 1
• Higher incidence in pediatric patients (ages 12+) compared to adults 1
• Symptoms: upper abdominal pain, jaundice, fever, clay-colored stools 1
• GLP-1 receptor agonists as a class show this association 5, 3

Acute Kidney Injury

• Risk from severe dehydration secondary to nausea, vomiting, and diarrhea 1
• Critical in patients with pre-existing kidney disease—can worsen renal function 2, 6
• Maintain adequate hydration, especially during dose escalation 5
• Use caution when initiating or escalating doses in renal impairment 2

Cardiovascular Events

• Increased heart rate at rest—monitor regularly 1
• Seek immediate care if heart racing/pounding lasts several minutes 1
• Acute myocardial infarction reported in clinical trials 3
• Modest blood pressure reduction typically occurs, but monitor 6

Serious Neuropsychiatric Effects

Suicidal Ideation and Depression

• Monitor for new or worsening mood changes, behaviors, or suicidal thoughts 1
• Call healthcare provider immediately if mental changes occur 1
• Depression and suicidal ideation reported in pharmacovigilance data 3
• Nine deaths (primarily male, from completed suicide) reported in EudraVigilance database 7
• Psychiatric adverse events comprised 1.2% of total reports but included severe/fatal outcomes 7

Diabetic Retinopathy Complications

• Increased risk in patients with type 2 diabetes, particularly those on insulin 6
• Hypothesized mechanism: rapid glucose reduction causing retinal changes 6
• Ensure eye examination within 12 months before starting therapy 6
• Monitor vision changes during treatment 1

Severe Allergic Reactions

• Stop Wegovy and seek emergency care for: 1
  • Swelling of face, lips, tongue, or throat
  • Severe rash or itching
  • Very rapid heartbeat
  • Breathing/swallowing problems
  • Fainting or severe dizziness
• Anaphylaxis and angioedema reported 1

Hypoglycemia (When Combined with Other Diabetes Medications)

• Severe risk when used with insulin or sulfonylureas 4, 5, 1
• Symptoms: dizziness, sweating, shakiness, blurred vision, confusion, fast heartbeat, slurred speech 1
• Check blood sugar before starting and regularly during treatment 1
• Dose adjustment of concomitant diabetes medications may be necessary 4

Gastrointestinal Complications

Severe Manifestations Beyond Common Side Effects

• Severe constipation and small bowel obstruction/ileus reported 2
• Gastroenteritis requiring medical attention 3
• Delayed gastric emptying increases pulmonary aspiration risk during anesthesia 8
  • Odds ratio 10.23 (95% CI: 2.94-35.82) in elective surgery 8
  • Consider stopping 1 week before procedures requiring anesthesia 8
• Rare case of transient intestinal ischemia reported 9

Monitoring Requirements

Essential surveillance to detect severe complications:

• Heart rate monitoring at each visit 1
• Blood glucose if on insulin/sulfonylureas 1
• Hydration status, especially with GI symptoms 1
• Mental health changes at every encounter 1
• Vision changes in diabetic patients 6
• Signs of gallbladder disease (abdominal pain, jaundice) 1
• Renal function if dehydration occurs 2, 1

Critical Contraindications

Absolute contraindications: 1

• Personal or family history of medullary thyroid carcinoma
• Multiple Endocrine Neoplasia syndrome type 2
• Prior serious hypersensitivity to semaglutide
• Pregnancy and breastfeeding 5

Common Pitfalls to Avoid

1. Failing to titrate slowly—rapid escalation increases severe GI complications 4, 3
2. Inadequate hydration counseling—leads to acute kidney injury 1
3. Not adjusting concomitant diabetes medications—causes severe hypoglycemia 4, 1
4. Ignoring psychiatric symptoms—delays intervention for suicidal ideation 1, 7
5. Proceeding with surgery without stopping medication—increases aspiration risk 8
6. Missing pre-treatment eye exam in diabetics—delays detection of retinopathy 6